Leadership Overview
Charles River has 6 executives leading key functions including strategy, operations, financial management, administrative coordination, and corporate communications.
Focused on accelerating drug and medical device development, Charles River delivers integrated research and manufacturing solutions to global clients, ensuring maximum speed and confidence throughout the entire product lifecycle.
Focused on accelerating drug and medical device development, Charles River delivers integrated research and manufacturing solutions to global clients, ensuring maximum speed and confidence throughout the entire product lifecycle.
Leadership Roles at Charles River
Birgit Girshick - Chief Executive Officer
Birgit Girshick, the Chief Executive Officer at Charles River, directs the overarching strategic vision for the organization. Overseeing the entire end-to-end portfolio, the Chief Executive Officer ensures that research, discovery, and safety assessment services meet the rigorous demands of global pharmaceutical and medical device clients. This leadership role involves driving operational excellence across international markets to maintain a competitive edge in drug development. By aligning scientific expertise with regulatory requirements, Birgit Girshick accelerates the path to market for critical healthcare innovations. The Chief Executive Officer maintains constant collaboration with the Board to refine long-term growth objectives and resource allocation. Through consistent focus on efficiency and scientific integrity, Girshick secures the company's position as a leader in the research and development services industry, ultimately supporting the delivery of life-saving solutions to patients worldwide.

Samira Amini - Corporate Vice President, Global RMS Divisional Chief Financial Officer
Samira Amini, the Corporate Vice President, Global RMS Divisional Chief Financial Officer at Charles River, oversees the financial health and fiscal planning for the Research Models and Services division. Managing complex budgetary frameworks, the Corporate Vice President, Global RMS Divisional Chief Financial Officer ensures that financial resources support the division's capacity for global research support. This leadership role involves analyzing market trends to forecast revenue growth and cost efficiency within the division's specialized service offerings. Samira Amini collaborates with operational leaders to optimize capital allocation, ensuring that investments in infrastructure and scientific talent yield maximum returns. By maintaining rigorous financial controls, the Corporate Vice President, Global RMS Divisional Chief Financial Officer supports the company's broader mission of accelerating drug development. Amini drives fiscal transparency and accountability, providing the data-driven insights required for informed decision-making. Through strategic financial management, Amini strengthens the division's ability to serve clients across the global healthcare landscape.
Nicole Angiolillo - Executive Assistant To Executive Vice President and Chief Financial Officer
Nicole Angiolillo, the Executive Assistant To Executive Vice President and Chief Financial Officer at Charles River, coordinates the administrative and strategic support functions for the finance department. Managing the complex schedule and communication flow for the Chief Financial Officer, the Executive Assistant To Executive Vice President and Chief Financial Officer ensures that executive time remains focused on high-impact financial initiatives. This role involves organizing critical meetings, preparing essential documentation for board reviews, and facilitating cross-departmental collaboration. Nicole Angiolillo maintains the integrity of financial reporting processes by ensuring timely access to information and resources. By managing the logistical demands of the finance leadership, the Executive Assistant To Executive Vice President and Chief Financial Officer enables the team to concentrate on the company's mission of accelerating drug and chemical development. Angiolillo provides the necessary administrative infrastructure to support the financial stability and growth of the organization, ensuring that executive priorities receive consistent and efficient attention.
Glenn Coleman - Corporate Executive VP & Chief Financial Officer
Glenn Coleman, the Corporate Executive VP & Chief Financial Officer at Charles River, directs the global financial strategy and capital structure of the organization. Overseeing financial planning, analysis, and investor relations, the Corporate Executive VP & Chief Financial Officer ensures that the company maintains the fiscal strength required to support its expansive end-to-end portfolio. This leadership role involves managing the financial risks associated with global research and manufacturing operations. Glenn Coleman drives the allocation of capital toward high-growth areas, such as advanced drug discovery and safety assessment technologies. By collaborating with the executive team, the Corporate Executive VP & Chief Financial Officer aligns financial performance with the company's long-term mission of accelerating medical innovation. Coleman monitors global economic conditions to adjust financial strategies, ensuring resilience and sustained profitability. Through disciplined fiscal management, Coleman provides the foundation for the company to continue delivering essential services to the global pharmaceutical and medical device industries.

Stacey Pauze - Chief of Staff
Stacey Pauze, the Chief of Staff at Charles River, manages the internal operational cadence and executive alignment across the organization. Coordinating high-priority initiatives, the Chief of Staff facilitates communication between leadership tiers to ensure seamless execution of corporate objectives. This role involves streamlining complex workflows related to drug discovery and safety assessment services, allowing the broader team to focus on client-facing deliverables. Stacey Pauze monitors progress on key strategic projects, identifying potential bottlenecks and implementing solutions to maintain project velocity. By bridging the gap between executive strategy and departmental implementation, the Chief of Staff optimizes organizational performance. Pauze maintains a comprehensive view of global operations, ensuring that resources align with the company's mission to accelerate medical device and chemical development. Through meticulous oversight and process improvement, the Chief of Staff drives the operational stability necessary for sustained success in the competitive research services sector.
Amy Cianciaruso - Corporate Senior Vice President, Chief Communications Officer
Amy Cianciaruso, the Corporate Senior Vice President, Chief Communications Officer at Charles River, directs the global messaging and reputation management strategy for the organization. Overseeing internal and external communications, the Corporate Senior Vice President, Chief Communications Officer ensures that the company's mission to accelerate drug and medical device development remains clear to all stakeholders. This leadership role involves crafting narratives that highlight the company's scientific expertise and regulatory capabilities. Amy Cianciaruso manages brand positioning across international markets, ensuring consistency in how the company engages with clients, investors, and the scientific community. By developing comprehensive communication plans, the Corporate Senior Vice President, Chief Communications Officer supports the company's growth objectives and market impact. Cianciaruso collaborates with other C-suite leaders to ensure that corporate messaging aligns with strategic initiatives. Through proactive engagement and strategic storytelling, Cianciaruso strengthens the company's reputation as a trusted partner in the global research and development services sector.
Explore Leadership Teams in Business Services
The Agency for Science, Technology and Research, also known as A*STAR, is a research organization that advances national priorities in health, economy, sustainability, and future technologies. The agency conducts scientific research and innovation across diverse fields, including electronics, cancer research, chemistry, water treatment, materials science, infectious diseases, genetics, and energy. Its work focuses on developing impactful science, such as energy-efficient AI systems, sustainable molecular catalysts, and novel RNA-based molecular tools, to drive research, innovation, and enterprise in the physical sciences and engineering.
Company Leadership
SS
CC
ANSER was founded in 1958 as a public service research institute organized as a not-for-profit corporation dedicated to informing decisions that shape the nation's future. The company provides program management and objective studies and analyses to the national security, homeland security, and public policy communities. ANSER also builds and leads technology development collaborations through its subsidiary, Advanced Technology International (ATI), specializing in organizing and managing research and development consortia on behalf of the federal government.
Company Leadership TF
CM
JP

Founded in 1967 and headquartered in Chicago, Illinois, Mérieux NutriSciences is a company that provides a range of tests and consultancy services to the food and nutrition industries.
Company Leadership NM
RV
MB
Fortrea is a global clinical research organization that specializes in navigating the complexities of clinical trials and research and development services. Founded in 2006, the company provides comprehensive clinical research solutions with a focus on scientific rigor and innovative problem-solving. Fortrea offers services that help transform promising medical ideas into proven therapies, supporting the entire clinical development process. With operations across North America, Europe, Asia Pacific, Africa, and South America, Fortrea serves clients in the pharmaceutical, biotechnology, and healthcare industries through its extensive network of research facilities and specialized teams.
Company Leadership
OC
EK